Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.33 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | CDK4 | P11802 | 1/20 | 0.32 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.32 |
| ▸ | CCND1 | P24385 | 1/20 | 0.32 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7528996 | 1.00 | MAPK1 (0.33) | MAPK1NTSR1HTTMAPTL3MBTL1 | |
| SCHEMBL7525791 | 0.89 | HTT (0.37) | MAPK1NTSR1HTTMAPTL3MBTL1 | |
| SCHEMBL7525798 | 0.89 | HTT (0.37) | MAPK1NTSR1HTTMAPTL3MBTL1 | |
| SCHEMBL7523822 | 0.87 | IDO1 (0.32) | MAPK1NTSR1HTTMAPTL3MBTL1 | |
| SCHEMBL7528754 | 0.87 | IDO1 (0.32) | MAPK1NTSR1HTTMAPTL3MBTL1 | |
| SCHEMBL7825257 | 0.85 | EZH2 (0.44) | HTTMAPTALDH1A1HPGDKDM4E | |
| SCHEMBL7825254 | 0.85 | EZH2 (0.44) | HTTMAPTALDH1A1HPGDKDM4E | |
| SCHEMBL7522297 | 0.79 | MEN1 (0.31) | HTTMAPTGAASTAT3SMN1; SMN2 | |
| SCHEMBL7522299 | 0.79 | MEN1 (0.31) | HTTMAPTGAASTAT3SMN1; SMN2 | |
| SCHEMBL7526413 | 0.78 | PTGER1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0975592-B1 | BENZYLOXY PRODIGIOSINE COMPOUNDS | PHARMACIA & UPJOHN SPA (IT) | 2002-06-05 | — | — | EP | claimed |
| US-20020049248-A1 | Alone or in combination for treatment of adult-T-cell leukemia- lymphoma | PHARMACIA & UPJOHN, SPA (IT) | 2002-04-25 | — | — | US | claimed |
| US-6369096-B1 | IMMUNOMODULATING AGENT, IMMUNOSUPPRESSANT | PHARMACIA & UPJOHN S.P.A. (IT) | 2002-04-09 | — | — | US | claimed |
| EP-0975592-B1 | BENZYLOXY PRODIGIOSINE COMPOUNDS | PHARMACIA & UPJOHN SPA (IT) | 2002-06-05 | — | — | EP | disclosed |
| US-20020049248-A1 | Alone or in combination for treatment of adult-T-cell leukemia- lymphoma | PHARMACIA & UPJOHN, SPA (IT) | 2002-04-25 | — | — | US | disclosed |
| US-6369096-B1 | IMMUNOMODULATING AGENT, IMMUNOSUPPRESSANT | PHARMACIA & UPJOHN S.P.A. (IT) | 2002-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049248-A1 | Alone or in combination for treatment of adult-T-cell leukemia- lymphoma | MALT1, BCL6, CD4 | MAPK1 343/4885NTSR1 2373/4885HTT 3078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.